IAA
GILD icon

Ironsides Asset Advisors’s Gilead Sciences GILD Stock Holding History

Ironsides Asset Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,000
Closed -$286K – 106
2016
Q4 		$286K Sell
4,000
-782
-16% -$58.1K 0.08% 129
2016
Q3 		$378K Buy
4,782
+782
+20% +$63.5K 0.1% 121
2016
Q2 		$334K Buy
4,000
+1,053
+36% +$93.5K 0.1% 116
2016
Q1 		$271K Buy
+2,947
New +$266K 0.07% 155

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ironsides Asset Advisors's GILD Position: Q1 2017 in Review

Ironsides Asset Advisors sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 4,000 shares — an estimated $286K sold.

Ironsides Asset Advisors first reported a position in GILD in Q1 2016 and held it in 4 quarters. The position peaked at $378K in Q3 2016. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Ironsides Asset Advisors reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Ironsides Asset Advisors sold 4,000 Gilead Sciences shares in Q1 2017, an estimated $286K.
  • Ironsides Asset Advisors first reported a position in Gilead Sciences in Q1 2016 and held it in 4 quarters.
  • Ironsides Asset Advisors's Gilead Sciences position peaked at $378K in Q3 2016.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Ironsides Asset Advisors's 13F filing for Q1 2017, filed 10 May 2017.